Skip to main content

Metastatic Bone Disease:Femur—Tibia

  • Chapter
Book cover Metastatic Bone Disease
  • 1300 Accesses

Abstract

Metastatic adenocarcinoma to the tibia can be a complicated problem that may be difficult to manage. However, reasonably good functional results are possible when managed with an appropriate team of cancer care professionals with a treatment algorithm tailored for each individual patient. Metastatic disease to the tibia is historically seen at later stages in the primary disease process; certainly more so than that of the proximal femur, the humerus, and the axial skeleton. Standard treatment protocols and algorithms for tibial disease are less specifically defined compared to those of the other appendicular long bones, and as such, the data are limited given short-term follow up, and the lower frequency of problems related to tibial disease. However, given improvement in medical therapy, alternative methods of stabilization, and megaprosthetic modularity, quality of life and function can be preserved with an appropriately aggressive algorithmic approach to this site of disease.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 79.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 99.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 139.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Landis SH, Murray T, Bolden S, Wingo PA. Cancer statistics, 1998. CA Cancer J Clin. 1998;48:6–29.

    Article  CAS  PubMed  Google Scholar 

  2. Coleman RE. Clinical features of Metastatic bone disease and risk of skeletal morbidity. Clin Cancer Res. 2006;12(Suppl 20). Accessed 15 Oct 2006.

    Google Scholar 

  3. Rock MG. Metastatic lesions of the humerus and the upper extremity. Instr Course Lect. 1992;41:329–33.

    CAS  PubMed  Google Scholar 

  4. Kelly CM, Wilkins RM, Eckardt JJ, Ward WG. Treatment of metastatic disease of the tibia. Clin Orthop Relat Res. 2003;415S:S219–29. Lippincott Williams and Wilkins, Inc.

    Article  Google Scholar 

  5. Coyler RA. Surgical stabilization of pathologic neoplastic fractures. Curr Probl Cancer. 1986;10:117–68.

    Article  Google Scholar 

  6. Leeson MC, Mackley JT, Carter JR. Metastatic skeletal disease distal to the elbow and knee. Clin Orthop. 1986;206:94–9.

    PubMed  Google Scholar 

  7. Baston OV. The function of the vertebral veins and their role in the spread of metastases. Clin Orthop. 1995;312:4–9.

    Google Scholar 

  8. Mirels H. Metastatic disease in long bones a proposed scoring system for diagnosing impending pathologic fractures. Clin Orthop 249: 256–264, 1989.

    Google Scholar 

  9. Geeter KD, Reynders P, Samson I, Broos PLO. Metastatic fractures of the tibia. Acta Orthopaedica Belgica. 2001;67:1.

    Google Scholar 

  10. Coleman RE, Lipton A, Roodman D, Guise TA, Boyce BF, Brufsky AM, et al. Metastasis and bone loss: advancing treatment and prevention. Cancer Treat Rev. 2010;36:615–20.

    Article  PubMed Central  PubMed  Google Scholar 

  11. Coleman RE. Metastatic bone disease: clinic features, pathophysiology and treatment strategies. Cancer Treat Rev. 2001;27(3):165–76.

    Article  CAS  PubMed  Google Scholar 

  12. Clohisy DR, Plaker D, Ramnarine MLE, Pekurovski I, Oursler MJ. Human breast cancer induces osteoclast activation and increases the number of osteoclasts at sites of tumor osteolysis. J Orthop Res. 1996;14:396–402.

    Article  CAS  PubMed  Google Scholar 

  13. Body JJ, Bartl R, Burkhardt P, et al. Current use of bisphosphonates in oncology. J Clin Oncol. 1998;16:3890–9.

    CAS  PubMed  Google Scholar 

  14. Coleman RE. Metastatic bone disease and the role of biochemical markers of bone metabolism in benign and malignant diseases. Canc Treat Rev. 2001;27:133–5.

    Article  CAS  Google Scholar 

  15. Pearse RN. New strategies for the treatment of metastatic bone disease. Clin Breast Canc Vol 8, Suppl 1. Dec 2007.

    Google Scholar 

  16. Hortobagyi GN. Moving into the future: treatment of bone metastases and beyond. Canc Treat Rev. 2005;31:S9–18.

    Article  CAS  Google Scholar 

  17. Eccles SA, Welch DR. Metastasis: recent discoveries and novel treatment strategies. Lancet. 2007;369:1742–57.

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  18. Kanis JA. Bone and cancer: pathophysiology and treatment of metastases. Bone 1995;17(2):101S–5S.

    Google Scholar 

  19. Sumathi VP, Jeys L, Legdeur N. Metastatic tumours of bone. Surgery. 2011;30(2). pgs 80–85 Elsevier.

    Google Scholar 

  20. Pakos EE, Gartzonikas DN, Tsekeris PG, Xenakis TA. Solitary tibial osteolytic lesion. Case Rep Med. 2009, Article ID 352085.

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Nicholas P. Webber MD .

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2016 Springer Science+Business Media New York

About this chapter

Cite this chapter

Webber, N.P. (2016). Metastatic Bone Disease:Femur—Tibia. In: Randall, R. (eds) Metastatic Bone Disease. Springer, New York, NY. https://doi.org/10.1007/978-1-4614-5662-9_25

Download citation

  • DOI: https://doi.org/10.1007/978-1-4614-5662-9_25

  • Publisher Name: Springer, New York, NY

  • Print ISBN: 978-1-4614-5661-2

  • Online ISBN: 978-1-4614-5662-9

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics